![Donnie McClurkin Defends President Obama, Calls For Pastors To Do Their Jobs [EXCLUSIVE VIDEO]](http://ronepraisehouston.files.wordpress.com/2013/05/donniemcclurkin-olgc.jpg?w=153)
![Billy Dorsey: I Wanted "Marathon" to Bring God Glory [EXCLUSIVE INTERVIEW]](http://ronepraisehouston.files.wordpress.com/2013/05/screen-shot-2013-05-07-at-4-21-55-pm.png?w=144)
via: news92fm.com
Patients who have been diagnosed with HER2-positive breast cancer may be eligible for a clinical study led by Baylor College of Medicine. The multi-institutional research will evaluate a new method of treatment that combines HER2-targeted therapies and excludes chemotherapy.
The study is a follow-up to a recent clinical trial that showed HER2-positive breast cancer patients using trastuzumab (Herceptin) and lapatinib (Tykerb) for 12 weeks – without chemotherapy. Patients reportedly showed a significant benefit in the eradication of breast cancer tumors. The data was released in May 2011 by the
